When is the submission deadline?

Submissions are due October 9, 2026.

It was issued by National Institutes Of Health. The work is located in United States.

Who is a good fit for this opportunity?

Clinical research organizations with expertise in pediatric obesity intervention. Experience implementing and evaluating anti-obesity pharmacological treatments. Ability to participate in collaborative, multi-institutional research consortia. Proven track record in youth health, wellness, and mental health initiatives. Capability to integrate research outcomes into clinical care settings.

Optimal Treatment Strategies Service (Due October 9, 2026)

Overview

Healthcare Services, Wellness & Biotech

United StatesPosted: June 9th, 2026Deadline: October 9th, 2026

Fit Score

Settle Intelligence

Settle helps teams find, qualify, and respond to RFPs. We continuously surface new opportunities, score them against your company strengths, and draft proposal responses so you can focus on the work that wins business.

Learn more about Settle

SUMMARY

RFP seeks a provider to participate in research and clinical testing of treatment strategies for youth using anti-obesity medication, with a focus on growth, development, and minimizing risks.

KEY REQUIREMENTS

Must be a clinical center capable of participating in a consortium
Must be a domestic U.S. entity
Must be an eligible applicant type (Nonprofit, Business, Education, or Government)
Must be able to collaborate on protocol development and common measures
Must be able to use a central laboratory and standardized procedures for data and biospecimen collection

TIMELINE

Last updated: June 8th, 2026.

Issuing Agency

National Institutes Of Health

Organization overview and procurement intelligence available on paid plans.

See Issuer Research

DESCRIPTION

The requesting agency is seeking a vendor to provide optimal treatment strategies services, specifically focusing on participation in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity. The aim is to identify approaches that maximize benefits and minimize risks associated with AOM use.

Intervention strategies should promote healthy growth and development, ensure adequate nutritional intake, encourage healthy eating and physical activity, and support mental health and quality of life. These strategies must be practical for use in clinical care settings.

Priority areas include evaluating the most effective developmental stage for initiating AOM treatment, determining optimal rates and amounts of weight loss, assessing the appropriate class, dose, frequency, and duration of medication, and analyzing the necessary content and intensity of adjunct lifestyle therapies. These elements are critical to support normal psychological and physical development and to potentially reduce lifelong dependence on AOMs.

Similar RFPs

Frequently asked questions

When is the submission deadline?: Submissions are due October 9, 2026.
Who issued this RFP?: It was issued by National Institutes Of Health. The work is located in United States.
Who is a good fit for this opportunity?: Clinical research organizations with expertise in pediatric obesity intervention
Experience implementing and evaluating anti-obesity pharmacological treatments
Ability to participate in collaborative, multi-institutional research consortia
Proven track record in youth health, wellness, and mental health initiatives
Capability to integrate research outcomes into clinical care settings

Stop missing winnable RFPs

Create a free account to search the full database, filter by your criteria, and have new RFPs matched to your business automatically.

See how Settle works